Who invested in Sideris Pharmaceuticals?
Sideris Pharmaceuticals's investors include MPM Capital, Hatteras Venture Partners and Osage University Partners.
United States · Series A startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by boston.comSEC filing: $17M sold, first sale Oct 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sideris Pharmaceuticals's investors include MPM Capital, Hatteras Venture Partners and Osage University Partners.
Sideris Pharmaceuticals has raised $33M across 2 rounds since 2013.
Sideris Pharmaceuticals's most recent round was a Series A of $32M in Oct 2013.
Its most recent round, $32M in Oct 2013, is also its largest on record.
Sideris Pharmaceuticals's first round on record, in Oct 2013, was backed by MPM Capital, Hatteras Venture Partners and Osage University Partners.
Sideris Pharmaceuticals's latest named round is a Series A, in Oct 2013.
Sideris Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.